PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Isoniazid - Tuberculosis
PAD Profile : Isoniazid - Tuberculosis
Keywords :
TB, antibiotic, antibacterial
Brand Names Include :
Rifater, Rifinah
Traffic Light Status
Status 1 of 1.
Status :
Red
Important
Formulations :
- Not Specified
Important Information :
Liaise with Chest Physician. Patients with multi-drug resistant TB should be treated by a specialist centre.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Guidelines
No guidelines returned.
Other Drugs
- Ethambutol hydrochloride
- Pyrazinamide
- Rifampicin
- Bedaquiline
- Delamanid
- Para-aminosalicylic acid
- Pretomanid
- Capreomycin
- Cycloserine
- Rifampicin with ethambutol, isoniazid and pyrazinamide
- Rifampicin with isoniazid
- Rifampicin with isoniazid and pyrazinamide
Other Indications
No indications returned.
Additional Documents
No additional documents returned.
Committee Recommendations
Date
Committee Name
Narrative
26 September 2007
Surrey Medicines Commissioners Group
September 2007 – The DH changed the regulations and advice relating to the treatment of TB. Patients requiring TB medication should be treated in specialist TB clinics where they will not be subject to prescription charges. FP10 prescriptions are not exempt from charges and should not be used.
Associated BNF Codes
05. Infections
05.01.09. Antituberculosis drugs